Park Ha Biological Technology Co. Ltd. is a holding company, which engages in the manufacture of skincare and cosmetic products. The company is headquartered in Wuxi, Jiangsu and currently employs 31 full-time employees. The company went IPO on 2024-12-27. The firm mainly operates its business through two segments. The Products Sales segment is engaged in providing skincare and cosmetic products under the brand name Park Ha as well as offering complimentary after-sales beauty services in physical stores. The Franchise Service segment is engaged in entering franchise agreements with its franchisees, pursuant to which the franchisees are granted permission to open and operate a store under the brand name Park Ha or Geni. The firm's products include Little Blue Injection Serum, Parkha Amino Acid Cleansing Foam and other products. The firm mainly conducts its business in domestic market.
Park Ha Biological Technology Co Ltdの主要な財務諸表は何ですか?
最新の財務諸表(Form-10K)によると、BAWAG Group AGの総資産は$0で、純損失は$0です。
PHHの主要な財務比率は何ですか?
BAWAG Group AGの流動比率は0、純利益率は0、1株当たり売上高は$0です。
Park Ha Biological Technology Co Ltdの収益はセグメントまたは地域別にどのように分けられていますか?
BAWAG Group AG の最大収益セグメントは Water Treatment Engineering で、最新の利益発表における収益は 138,130,000,000 です。地域別に見ると、Japan が BAWAG Group AG の主要市場であり、収益は 100,225,000,000 です。
Park Ha Biological Technology Co Ltdは収益を上げていますか?
いいえ、最新の財務諸表によると、BAWAG Group AGの純損失は$0です。
Park Ha Biological Technology Co Ltdに負債はありますか?
いいえ、BAWAG Group AGの負債は0です。
Park Ha Biological Technology Co Ltdの発行済株式数は何株ですか?